Last reviewed · How we verify
CYP2C19 probe
At a glance
| Generic name | CYP2C19 probe |
|---|---|
| Also known as | Omeprazole (20 mg) |
| Sponsor | Repros Therapeutics Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Nausea
- Fatigue
- Diarrhoea
- Vomiting
- Dizziness
- Flatulence
- Dysgeusia
- Upper respiratory tract infection
- Insomnia
- Abdominal distension
- Abdominal pain upper
- Constipation
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CYP2C19 probe CI brief — competitive landscape report
- CYP2C19 probe updates RSS · CI watch RSS
- Repros Therapeutics Inc. portfolio CI